BridgeBio Pharma (BBIO) Stock: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$67.25
0.34 (0.51%)
▲
5d:
+2.56%
30d:
-12.09%
90d:
-13.5%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BBIO trades at premium valuation expecting 127.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: BBIO trades at premium valuation expecting 127.6% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $67.25, which is considered slightly low relative to its 30-day fair value range of $66.63 to $76.86. From a valuation perspective, the stock is trading at a premium (Forward PE: 2445.4) compared to its historical average (207.4). At these levels, the market is pricing in 127.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $64.36, while resistance sits at $70.00.
Market Sentiment: BBIO scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $109.10 (+62.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $64.36, while resistance sits at $70.00.
Market Sentiment: BBIO scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $109.10 (+62.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$66.63 -
$76.86
Company Quality Score
76/100
(STRONG BUY)
Volume Confirmation
HIGH
Confidence Score
85.7%
Protect Your Profits
Holding BBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (91/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 62.2% below Wall St target ($109.10)
- BEARISH: Market expects 127.6% growth - appears too optimistic based on history
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$66.63 -
$76.86
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$64.36
Resistance Level
$70.00
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2445.45
Wall Street Target
$109.10
(+62.2%)
Revenue Growth (YoY)
120.4%
Profit Margin
-97.0%
Valuation Premium vs History
+127.6% premium
PE vs Historical
2445.5 vs 207.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+127.6%
(market-implied from PE analysis)
1-Year Target
$100.88
(+50%)
2-Year Target
$151.31
(+125%)
3-Year Target
$226.97
(+238%)
3-Yr Target (if PE normalizes)
(PE: 2445→207)
PE COMPRESSION
$19.25
(-71%)
Significant PE compression expected
Share & Embed Analysis
Last updated: October 03, 2026 3:39 AM ET
Data refreshes hourly during market hours. Next update: 4:39 AM
Data refreshes hourly during market hours. Next update: 4:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-04-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 51 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$107 | 67 BUY |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
